Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O

Journal of Medical Virology

Volumn 51, Issue 3, 1997, Pages 202-209

  Nkengasong, John N ^a,b   Fransen, Katrien ^a   Willems, Betty ^a   Karita, Etienne ^a   Vingerhoets, Johan ^a   Kestens, Luc ^a   Colebunders, Robert ^a   Piot, Peter ^a   Van Der Groen, Guido ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Project RETRO CI Abidjan   (Côte d’Ivoire)

Author keywords

HIV 1; pathogenic course; viral burden

Indexed keywords

ADULT; ARTICLE; BELGIUM; CASE REPORT; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; VIRUS PATHOGENESIS; VIRUS STRAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FOLLOW-UP STUDIES; HIV ANTIBODIES; HIV-1; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; SEXUAL PARTNERS; T-LYMPHOCYTES; TIME FACTORS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030992618     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199703)51:3<202::AID-JMV10>3.0.CO;2-M     Document Type: Article

References (46)

1. Arendrup M, Nielsen CM, Mathiesen LR, Lindhardt BO, Scheibel E, Nielsen JO (1992): Neutralizing antibodies against two HIV-1 strains in consecutively collected serum samples: Cross neutralization and association to HIV-1 related diseases. Scandinavian Journal of Infectious Disease 24:21-28.
2. Barré-Sinoussi F, Cherman JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Daugnet C, Axler-Blin C, Brun-Vezinet F, Rouzioux C, Rosebaum W, Montagnier L (1993): Isolation of a T-lymphotrophic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-871.
3. Björling E, Scarlatti G, von Gegerfelt A, Albert J, Biberfeld G, Choidi F, Norrby E, Fenyo ME (1993): Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology 193:528-530.
4. Boom RC, Sol CJA, Salimans MMM, Jansen CL, Werteim-van Dillen PME, van der Noordaa J (1990): Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 28: 495-503.
5. Burns DP, Desrosiers RC (1992): A caution on the use of SIV/HIV Gag antigen detection systems in neutralization assays. AIDS Research and Human Retroviruses 8:1189-1192.
6. Castro BA, Weiss CD, Wiviott LD, Levy JA (1988): Optimal condition for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. Journal of Clinical Microbiology 26:2371-2376.
7. Centers for Diseases Control (1992): Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (RR-17): 1-19.
8. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey MA, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C, Klatzmann D, Champalimaud JL, Montagnier L (1986): Isolation of a new human retrovirus from West-African patients with AIDS. Science 233:343-346.
9. Connor RI, Mohri H, Cao Y, Ho DD (1993): Increased viral burden and cytopathicity correlate temporally with CD4+T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1 infected individuals. Journal of Virology 67:1772-1777.
10. De Beenhouwer H, Verhaert HN, Claeys H, Vermylen C (1992): Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction. Vox Sanguinis 63:198-203.
11. De Leys, Van der Borght B, Vanden Haesevelde M, Heyndrickx L, Van Geel A, Wauters C, Bernaerts R, Saman E, Nys P, Willems B, Taelman H, van der Groen G, Piot P, Tersmette T, Huisman JG (1990): Isolation and partial characterization of an unusual human immunodeficiency retrovirus from 2 persons of West-Central African origin. Journal of Virology 64:1207-1216.
12. Descamps D, Collin G, Loussert-Ajaka I, Saragosti S, Simon F, Brun-Vézinet F (1995): HIV-1 group O sensitivity to antiretroviral drugs. AIDS 9:977-978.
13. Foire J, Björndal A, Aperia-Peipke K, Di Stefano M, Angarano G, Pastore G, Gaines H, Fenyö EM, Albert J (1994): The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 204:297-303.
14. Forte SE, Byron KS, Sullivan JL, Somasundaran M (1994): Non-syncytium-inducing HIV type 1 isolates from infected individuals replicate in MT-2 cells. AIDS Research and Human Retroviruses 10:1613-1618.
15. Fransen K, Zhong P, De Beenhouwer H, Carpels G, Peeters M, Louwagie J, Janssens W, Piot P, van der Groen G (1994): Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Molecular and Cellular Probes 8:317-322.
16. Gallo RC, Salahuddin SZ, Popovic M, Shearer M, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PD (1984): Frequent detection and isolation of cythopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500-503.
17. Gurtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, Kaptue L (1994): A new subtype of human immunodeficiency virus type 1 (MVP 5180) from Cameroon. Journal of Virology 68:1581-1585.
18. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995): Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
19. Holodniy M, Katzenstein DA, Sengupta S, Wang MA, Casipit C, Schwartz DH, Konrad M, Groves E, Merigan TC (1991): Detection and quantification of human immunodeficiency virus RNA in patient serum by use of polymerase chain reaction. Journal of Infectious Diseases 163:862-866.
20. Koot M, Vos AHV, Keet IPM, de Goede REY, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, Tersmette M (1992): HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 6:49-54.
21. Kunanusont C, Foy HM, Kreiss JK, Rerks-Ngarm S, Phanuphak P, Rakt-ham S, Pau C-P, Young NL (1995): HIV-1 subtypes and male-to-female transmission in Thailand. Lancet 345:1079-1083.
22. Leitner T, Escanilla D, Marquina S, Wahlberg J, Broström C, Hansson HB, Uhlen M, Albert J (1995): Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmission in Sweden. Virology 209:136-146.
23. Looney DJ, Hayashi S, Nicklas M, Redfield R, Broder S, Wong-Staal F, Mitsuya H (1990): Difference in the interaction of HIV-1 and HIV-2 with CD4. Journal of Acquired Immune Deficiency Syndrome 3:649-657.
24. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Courouce AM, Brun-Vézinet F, Simon F (1994): HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 343:1393-1394.
25. Loussert-Ajaka I, Chaix ML, Korber B, Letourrneur F, Gomas E, Allen E, Ly TD, Brun-Vezinet F, Simon F, Saragosti S (1995): Variability of HIV type 1 group O strains isolated from Cameroonian patients living in France. Journal of Virology 69:5640-5649.
26. Marlink RG, Kanki PJ, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsich CC, Dia MC, Gueye EH, Hellinger J, Gueye-Ndiaye A, Sankale J-L, Ndoye I, Mboup S, Essex M (1994): Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265:1587-1590.
27. Myers G, Korber B, Berzofsky J, Smith RF, Pavlakis GN: "Human Retroviruses and AIDS Database" Los Alamos, NM: Los Alamos National Laboratory, 1993.
28. Nkengasong JN, Peeters M, vanden Haesevelde M, Musi S, Willems B, Ndumbe P, Piot P, van der Groen G (1993): Antigenic evidence of the aberrant HIV-1ANT70 virus in Cameroon and Gabon. AIDS 7:1536-1538.
29. Nkengasong J, Peeters M, Ndumbe P, Janssens W, Willems B, Fransen K, Ngolle M, Piot P, van der Groen G (1994a): Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1 infected individuals. AIDS 8:1089-1096.
30. Nkengasong J, Janssens W, Heydrickx L, Fransen K, Ndumbe P, Motte J, Leonaers A, Ngolle M, Ayuk J, Piot P, van der Groen G (1994b): Genotypic subtypes of HIV-1 in Cameroon. AIDS 8:1405-1412.
31. Nkengasong J, Peeters M, Zhong P, Willems B, Janssens W, Heyndrickx L, Fransen K, Ndumbe P, Gershy-Damet G-M, Nys P, Kestens L, Piot P, van der Groen G (1995): Biological phenotypes of HIV-1 subtypes A and B strains of diverse origins. Journal of Medical Virology 47:278-284.
32. Nyambi P, Nkengasong J, Peeters M, Simon F, Eberle J, Janssens W, Fransen K, Willems B, Vereecken K, Heyndrickx L, Piot P, van der Groen G (1995): Reduced capacity of antibodies from patients infected with HIV-1 group O to neutralize primary isolates of HIV-1 group M viruses. Journal of Infectious Diseases 172:1228-1237.
33. Phillips AN, Lee AC, Elford J, Janossy G, Timms A, Bofill M, Kernoff PBA (1991): Serial CD4 lymphocyte counts and development of AIDS. Lancet 337:389-392.
34. Schable C, Zekeng L, Pau CP, Hu D, Kaptue L, Gurtler L, Dondero T, Tsague J-M, Schochetman G, Jaffe H, George J-R (1994): Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 344:1333-1334.
35. Schuitemaker H, Koot M, Koostra NA, Derksen MW, Goede de RE, Steenwijk van RP, Lange JMA, Eeftinck Schattenkerk JKM, Miedema F, Tersmette M (1992): Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic virus populations. Journal of Virology 66:1354-1360.
36. Shpaer EG, Mullins JI (1993). Rates of amino acid changes in the envelope protein correlate with pathogenicity of primate lentiviruses. Journal of Molecular Evolution 37:57-65.
37. Simon F, Matheron S, Tamalet C, Loussert-Ajaka I, Bartezak S, Pépin JM, Dhiver C, Gamba E, Elbim C, Gastaut JA, Saimot AG, Brun-Vézinet F (1993): Cellular and plasma viral load in patients infected with HIV-2. AIDS 7:1411-141.
38. Tamalet C, Simon F, Dhiver C, Matheron S, de Micco P, Gastao JA, Brun-Vézinet F (1995): Autologous neutralizing antibodies and viral load in HIV-2 infected individuals. AIDS 9:9091.
39. Tersmette M, Gruters RA, de Wolf F, de Goede REY, Lange JMA, Schellekens PTA, Goudsmit J, Huisman HG, Miedema F (1989): Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome obtained from studies on a panel of sequential HIV isolates. Journal of Virology 63:2118-2125.
40. Tsang ML, Evans LA, McQueen P, Hurren L, Byrne C, Penny R, Tindall B, Copper DA (1994): Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion. Journal of Infectious Disease 170:1141-1147.
41. Valentin A, Albert J, Fenyö M, Asjo B (1994): Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. Journal of Virology 68:6684-6689.
42. Vanden Haesevelde M, Decourt JL, Deleys R, Vanderborght B, van der Groen G, van Heuverswijn H, Saman E (1994): Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. Journal of Virology 68: 1586-1596.
43. Van Kerckhoven I, Fransen K, Peeters M, De Beenhouwer H, Piot P, van der Groen G (1994): Quantitation of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. Journal of Clinical Microbiology 32:1669-1673.
44. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak M, Hahn B, Sag M, Shaw G (1995): Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:123-126.
45. Wong-staal F, Shaw GM, Hahn BH, Salahuddin SZ, Popovic M, Markham P, Redfield R, Gallo R (1985): Genomic diversity of human T-lymphotrophic virus type III (HTLV-III). Science 229:759-762.
46. Wrin T, Crawford L, Sawyer L, Weber P, Sheppard HW, Hanson CV (1994): Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndrome 7:211-219.